| Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation GJ Freeman, AJ Long, Y Iwai, K Bourque, T Chernova, H Nishimura, ... The Journal of experimental medicine 192 (7), 1027-1034, 2000 | 6510 | 2000 |
| PD-1 and its ligands in tolerance and immunity ME Keir, MJ Butte, GJ Freeman, AH Sharpe Annu. Rev. Immunol. 26 (1), 677-704, 2008 | 6407 | 2008 |
| Restoring function in exhausted CD8 T cells during chronic viral infection DL Barber, EJ Wherry, D Masopust, B Zhu, JP Allison, AH Sharpe, ... Nature 439 (7077), 682-687, 2006 | 5029 | 2006 |
| PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma SM Ansell, AM Lesokhin, I Borrello, A Halwani, EC Scott, M Gutierrez, ... New England Journal of Medicine 372 (4), 311-319, 2015 | 4043 | 2015 |
| PD-L2 is a second ligand for PD-1 and inhibits T cell activation Y Latchman, CR Wood, T Chernova, D Chaudhary, M Borde, I Chernova, ... Nature immunology 2 (3), 261-268, 2001 | 3823 | 2001 |
| Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ... Nature medicine 24 (10), 1550-1558, 2018 | 3617 | 2018 |
| PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression CL Day, DE Kaufmann, P Kiepiela, JA Brown, ES Moodley, S Reddy, ... Nature 443 (7109), 350-354, 2006 | 3320 | 2006 |
| The B7 family revisited RJ Greenwald, GJ Freeman, AH Sharpe Annu. Rev. Immunol. 23 (1), 515-548, 2005 | 3301 | 2005 |
| CTLA-4 can function as a negative regulator of T cell activation TL Walunas, DJ Lenschow, CY Bakker, PS Linsley, GJ Freeman, ... Immunity 1 (5), 405-413, 1994 | 2826 | 1994 |
| CD4+ CD25high regulatory cells in human peripheral blood C Baecher-Allan, JA Brown, GJ Freeman, DA Hafler The Journal of Immunology 167 (3), 1245-1253, 2001 | 2643 | 2001 |
| The B7–CD28 superfamily AH Sharpe, GJ Freeman Nature Reviews Immunology 2 (2), 116-126, 2002 | 2580 | 2002 |
| Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection SD Blackburn, H Shin, WN Haining, T Zou, CJ Workman, A Polley, ... Nature immunology 10 (1), 29-37, 2009 | 2445 | 2009 |
| PD-L1 regulates the development, maintenance, and function of induced regulatory T cells LM Francisco, VH Salinas, KE Brown, VK Vanguri, GJ Freeman, ... Journal of Experimental Medicine 206 (13), 3015-3029, 2009 | 2426 | 2009 |
| Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens MM Gubin, X Zhang, H Schuster, E Caron, JP Ward, T Noguchi, Y Ivanova, ... Nature 515 (7528), 577-581, 2014 | 2196 | 2014 |
| Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses MJ Butte, ME Keir, TB Phamduy, AH Sharpe, GJ Freeman Immunity 27 (1), 111-122, 2007 | 2171 | 2007 |
| Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease L Monney, CA Sabatos, JL Gaglia, A Ryu, H Waldner, T Chernova, ... Nature 415 (6871), 536-541, 2002 | 1979 | 2002 |
| The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection AH Sharpe, EJ Wherry, R Ahmed, GJ Freeman Nature immunology 8 (3), 239-245, 2007 | 1910 | 2007 |
| Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy SJ Im, M Hashimoto, MY Gerner, J Lee, HT Kissick, MC Burger, Q Shan, ... Nature 537 (7620), 417-421, 2016 | 1841 | 2016 |
| Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints S Koyama, EA Akbay, YY Li, GS Herter-Sprie, KA Buczkowski, ... Nature communications 7 (1), 10501, 2016 | 1506 | 2016 |
| Tissue expression of PD-L1 mediates peripheral T cell tolerance ME Keir, SC Liang, I Guleria, YE Latchman, A Qipo, LA Albacker, ... The Journal of experimental medicine 203 (4), 883-895, 2006 | 1489 | 2006 |
